Income Statement Innoviva, Inc.

Equities

INVA

US45781M1018

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2026-05-08 pm EDT			5-day change	1st Jan Change
22.89 ^USD	+0.39%		-0.95%	+14.51%

May. 06	Earnings Flash (INVA) Innoviva, Inc. Reports Q1 Revenue $98.0M, vs. FactSet Est of $101.6M	MT
May. 06	Innoviva, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

4b1ed549d0e58b5f1a7f842f6b6.-sFMGrqZ6Kzub5HB9b6ZizeEoA--PUFWOcIquI9uRHo.u6g8ff_KuvyxA6CLuPDc7G7U9Ufdew0jdboT4uwHLi-vjBtS39Gy38ME1A

Published financial data: INNOVIVA, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	-	19.69M	71.62M	117M	175M
Other Revenues, Total	392M	312M	239M	242M	236M
Total Revenues	392M	331M	310M	359M	411M
Cost of Goods Sold, Total	576K	55.22M	49.4M	36.43M	103M
Gross Profit	391M	276M	261M	322M	308M
Selling General & Admin Expenses, Total	12.89M	58.24M	98.23M	116M	113M
Amortization of Goodwill and Intangible Assets - (IS)	-	5.58M	21.78M	25.9M	26.28M
Other Operating Expenses, Total	12.89M	63.82M	120M	142M	140M
Operating Income	378M	212M	141M	181M	169M
Interest Expense, Total	-19.07M	-15.79M	-19.16M	-22.21M	-16.7M
Interest And Investment Income	1.84M	6.37M	15.82M	19.14M	21.09M
Net Interest Expenses	-17.23M	-9.42M	-3.34M	-3.07M	4.39M
Other Non Operating Income (Expenses)	-3.63M	-3.37M	-4.97M	-3M	-2.86M
EBT, Excl. Unusual Items	358M	200M	133M	175M	170M
Merger & Related Restructuring Charges	-	-5.3M	-27.16M	-13.82M	-4.84M
Gain (Loss) On Sale Of Investments	91.03M	-153M	88.52M	-123M	162M
Gain (Loss) On Sale Of Assets	-	267M	-	-	-
Legal Settlements	-3.3M	-	-	-	-
Other Unusual Items	-	-20.66M	-	-	-
EBT, Incl. Unusual Items	445M	287M	194M	37.39M	327M
Income Tax Expense	76.44M	66.69M	14.38M	14M	55.7M
Earnings From Continuing Operations	369M	220M	180M	23.39M	271M
Net Income to Company	369M	220M	180M	23.39M	271M
Minority Interest	-103M	-6.34M	-	-	-
Net Income - (IS)	266M	214M	180M	23.39M	271M
Net Income to Common Incl Extra Items	266M	214M	180M	23.39M	271M
Net Income to Common Excl. Extra Items	266M	214M	180M	23.39M	271M
Per Share Items
Net EPS - Basic	3.24	3.07	2.75	0.37	4.02
Basic EPS - Continuing Operations	3.24	3.07	2.75	0.37	4.02
Basic Weighted Average Shares Outstanding	82.06M	69.64M	65.44M	62.73M	67.4M
Net EPS - Diluted	2.87	2.37	2.2	0.36	3.3
Diluted EPS - Continuing Operations	2.87	2.37	2.2	0.36	3.3
Diluted Weighted Average Shares Outstanding	94.31M	95.25M	86.88M	74.19M	84.76M
Normalized Basic EPS	1.47	1.7	1.27	1.74	1.58
Normalized Diluted EPS	1.28	1.24	0.95	1.47	1.25
Payout Ratio	-	-	-	-	-
Supplemental Items
EBITDA	378M	218M	177M	207M	195M
EBITA	378M	218M	163M	207M	195M
EBIT	378M	212M	141M	181M	169M
EBITDAR	-	-	178M	208M	197M
Total Revenues (As Reported)	392M	331M	310M	359M	411M
Effective Tax Rate - (Ratio)	17.17	23.24	7.41	37.43	17.04
Current Domestic Taxes	7K	41.29M	9.98M	26.61M	10.06M
Current Foreign Taxes	-	-	-	-	1.8M
Total Current Taxes	7K	41.29M	9.98M	26.61M	11.85M
Deferred Domestic Taxes	76.43M	25.4M	4.4M	-12.62M	43.85M
Total Deferred Taxes	76.43M	25.4M	4.4M	-12.62M	43.85M
Normalized Net Income	120M	118M	82.96M	109M	106M
Interest on Long-Term Debt	19.07M	15.79M	19.16M	22.21M	16.7M
Supplemental Operating Expense Items
General and Administrative Expenses	12.89M	-	-	-	-
Research And Development Expense From Footnotes	576K	41.43M	33.92M	13.65M	30.6M
Net Rental Expense, Total	-	-	1.62M	1.21M	1.52M
Imputed Operating Lease Interest Expense	-	-	437K	415K	475K
Imputed Operating Lease Depreciation	-	-	1.18M	799K	1.04M
Stock-Based Comp., COGS (Total)	-	2.04M	1.19M	334K	522K
Stock-Based Comp., G&A Exp. (Total)	2.02M	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	-	5.3M	4.64M	6.04M	8.93M
Total Stock-Based Compensation	2.02M	7.35M	5.84M	6.37M	9.45M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	202M	291M	194M	305M	551M
Short Term Investments	-	-	-	108M	15.73M
Total Cash And Short Term Investments	202M	291M	194M	412M	567M
Accounts Receivable, Total	111M	64.07M	84.08M	86.37M	93.32M
Total Receivables	111M	64.07M	84.08M	86.37M	93.32M
Inventory	-	55.9M	40.74M	33.72M	39.17M
Prepaid Expenses	1.44M	29.56M	21.63M	21.06M	26.72M
Other Current Assets, Total	-	2.93M	4.26M	656K	1.64M
Total Current Assets	314M	444M	344M	554M	728M
Net Property Plant And Equipment	12K	3.44M	3.02M	2.97M	12.48M
Long-term Investments	484M	403M	561M	394M	598M
Goodwill	-	26.71M	17.9M	17.9M	17.9M
Other Intangibles, Total	-	253M	230M	208M	182M
Deferred Tax Assets Long-Term	17.33M	-	-	12.05M	-
Deferred Charges Long-Term	111M	97.61M	83.78M	69.96M	56.14M
Other Long-Term Assets, Total	108K	4.3M	3.27M	41.48M	40.74M
Total Assets	926M	1.23B	1.24B	1.3B	1.64B
Liabilities
Accounts Payable, Total	27K	2.94M	6.72M	2.13M	4.97M
Accrued Expenses, Total	5.67M	29.63M	28.93M	27.49M	31.64M
Current Portion of Long-Term Debt	-	98.83M	-	198M	8.12M
Current Portion of Leases	109K	1.32M	1.21M	1.57M	418K
Current Income Taxes Payable	-	154K	-	-	274K
Unearned Revenue Current, Total	-	2.09M	1.28M	1.13M	4.27M
Other Current Liabilities	-	-	-	5.3M	-
Total Current Liabilities	5.81M	135M	38.13M	236M	49.7M
Long-Term Debt	395M	512M	516M	319M	312M
Long-Term Leases	-	2.38M	1.64M	1.18M	10.87M
Unearned Revenue Non Current	-	-	-	-	-
Deferred Tax Liability Non Current	-	5.77M	563K	-	31.79M
Other Non Current Liabilities	-	10.47M	12.11M	53.23M	58.13M
Total Liabilities	400M	666M	569M	610M	462M
Common Stock, Total	696K	692K	633K	627K	747K
Additional Paid In Capital	1.26B	1.16B	1.09B	692M	903M
Retained Earnings	-456M	-205M	-25.19M	-1.8M	269M
Treasury Stock	-394M	-394M	-394M	-	-
Comprehensive Income and Other	-	-	-	-	-
Total Common Equity	415M	566M	675M	691M	1.17B
Minority Interest	111M	-	-	-	-
Total Equity	526M	566M	675M	691M	1.17B
Total Liabilities And Equity	926M	1.23B	1.24B	1.3B	1.64B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	69.57M	68.13M	63.23M	62.68M	74.07M
ECS Total Common Shares Outstanding	69.57M	69.19M	63.31M	62.66M	74.64M
Book Value / Share	5.96	8.18	10.66	11.03	15.71
Tangible Book Value	415M	286M	427M	465M	973M
Tangible Book Value Per Share	5.96	4.14	6.74	7.42	13.03
Total Debt	395M	615M	519M	521M	331M
Net Debt	193M	324M	325M	108M	-235M
Debt Equivalent Oper. Leases	-	-	12.94M	9.71M	12.12M
Minority Interest, Total (Incl. Fin. Div)	111M	-	-	-	-
Equity Method Investments, Total	-	-	117M	52.29M	194M
Account Code - Inventory Valuation	3	5	5	5	5
Inventories - Raw Materials, Total	-	5.76M	11.26M	11.11M	16.33M
Inventories - Work In Process, Total	-	25.05M	15.67M	20.53M	17.87M
Inventories - Finished Goods, Total	-	25.09M	13.81M	2.08M	4.97M
Full Time Employees	5	101	112	127	159

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	266M	214M	180M	23.39M	271M
Depreciation & Amortization - CF	9K	108K	13.92M	128K	128K
Amortization of Goodwill and Intangible Assets - (CF)	-	5.58M	21.78M	25.9M	26.28M
Depreciation & Amortization, Total	9K	5.69M	35.7M	26.03M	26.4M
Amortization of Deferred Charges, Total - (CF)	22.96M	15.88M	2.06M	15.93M	15.71M
(Gain) Loss From Sale Of Asset	-	-267M	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-89.31M	153M	-88.52M	123M	-162M
Asset Writedown & Restructuring Costs	-	10.02M	-	-	9.37M
Stock-Based Compensation (CF)	2.02M	7.35M	5.84M	6.37M	9.45M
Other Operating Activities, Total	179M	55.41M	31.05M	481K	50.58M
Change In Accounts Receivable	-16.78M	9.79M	-20M	-2.29M	-6.95M
Change In Inventories	-	280K	-12M	-6.81M	-12.92M
Change In Accounts Payable	-39K	92K	3.78M	-4.58M	2.83M
Change in Unearned Revenues	-	-755K	-817K	-151K	3.14M
Change In Income Taxes	-	10.03M	1.72M	41.48M	4.06M
Change in Other Net Operating Assets	-54K	-12.57M	2.53M	-34.58M	-14.33M
Cash from Operations	364M	202M	141M	189M	197M
Capital Expenditure	-	-67K	-411K	-270K	-1.13M
Sale of Property, Plant, and Equipment	-	-	-	101K	12K
Cash Acquisitions	-	-136M	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-4M	-9.37M
Investment in Marketable and Equity Securities, Total	43.72M	79.47M	-66.35M	-59.62M	50.98M
Cash from Investing	43.72M	-56.63M	-66.76M	-63.79M	40.5M
Long-Term Debt Issued, Total	-	253M	-	-	-
Total Debt Issued	-	253M	-	-	-
Long-Term Debt Repaid, Total	-	-165M	-96.2M	-	-25K
Total Debt Repaid	-	-165M	-96.2M	-	-25K
Issuance of Common Stock	1.17M	370K	170K	1.47M	13.25M
Repurchase of Common Stock	-394M	-8.58M	-75.8M	-14.92M	-4.68M
Common Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Other Financing Activities, Total	-59.46M	-135M	-	-	-
Cash from Financing	-452M	-55.57M	-172M	-13.45M	8.55M
Net Change in Cash	-44.96M	89.52M	-97.54M	111M	246M
Supplemental Items
Cash Interest Paid	9.93M	11.74M	11.38M	10.36M	10.35M
Cash Income Tax Paid (Refund)	-	53.86M	-	11.79M	19.11M
Levered Free Cash Flow	233M	140M	123M	151M	122M
Unlevered Free Cash Flow	235M	148M	133M	163M	131M
Change In Net Working Capital	16.99M	11.2M	-3.86M	-8.01M	13.93M
Net Debt Issued / Repaid	-	87.4M	-96.2M	-	-25K

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	24.56	12.3	7.12	8.88	7.18
Return on Total Capital	24.71	12.63	7.43	9.39	7.76
Return On Equity %	65.06	40.35	28.97	3.42	29.09
Return on Common Equity	55.7	43.63	28.97	3.42	29.09
Margin Analysis
Gross Profit Margin %	99.85	83.33	84.09	89.84	74.94
SG&A Margin	3.29	17.58	31.64	32.25	27.56
EBITDA Margin %	96.57	65.79	56.93	57.63	47.41
EBITA Margin %	96.56	65.76	52.45	57.59	47.37
EBIT Margin %	96.56	64.07	45.43	50.37	40.99
Income From Continuing Operations Margin %	94.12	66.48	57.89	6.52	65.92
Net Income Margin %	67.84	64.56	57.89	6.52	65.92
Net Avail. For Common Margin %	67.84	64.56	57.89	6.52	65.92
Normalized Net Income Margin	30.75	35.72	26.72	30.43	25.85
Levered Free Cash Flow Margin	59.35	42.39	39.7	42.13	29.68
Unlevered Free Cash Flow Margin	60.06	44.75	42.89	45.41	31.76
Asset Turnover
Asset Turnover	0.41	0.31	0.25	0.28	0.28
Fixed Assets Turnover	19.59K	186.99	96.21	119.85	53.24
Receivables Turnover (Average Receivables)	-	0.23	0.97	1.37	1.95
Inventory Turnover (Average Inventory)	-	-	1.02	0.98	2.83
Short Term Liquidity
Current Ratio	54.02	3.29	9.03	2.35	14.64
Quick Ratio	53.77	2.63	7.28	2.11	13.28
Operating Cash Flow to Current Liabilities	62.65	1.49	3.7	0.8	3.96
Days Sales Outstanding (Average Receivables)	-	1.62K	377.52	266.64	187.55
Days Outstanding Inventory (Average Inventory)	-	-	357.01	374.03	129.04
Average Days Payable Outstanding	29.47	-	51.47	55.04	11.93
Cash Conversion Cycle (Average Days)	-	-	683.07	585.62	304.66
Long Term Solvency
Total Debt/Equity	75.06	108.64	76.89	75.33	28.24
Total Debt / Total Capital	42.88	52.07	43.47	42.96	22.02
LT Debt/Equity	75.04	90.94	76.71	46.38	27.51
Long-Term Debt / Total Capital	42.86	43.59	43.37	26.46	21.46
Total Liabilities / Total Assets	43.23	54.06	45.72	46.88	28.27
EBIT / Interest Expense	19.84	13.45	7.36	8.14	10.1
EBITDA / Interest Expense	19.84	13.81	9.31	9.36	11.77
(EBITDA - Capex) / Interest Expense	19.84	13.8	9.29	9.35	11.7
Total Debt / EBITDA	1.04	2.82	2.91	2.5	1.69
Net Debt / EBITDA	0.51	1.48	1.82	0.52	-1.2
Total Debt / (EBITDA - Capex)	1.04	2.82	2.92	2.51	1.7
Net Debt / (EBITDA - Capex)	0.51	1.48	1.83	0.52	-1.2
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	16.35	-15.45	-6.3	15.54	14.67
Gross Profit, 1 Yr. Growth %	16.8	-29.44	-8.76	23.45	-4.58
EBITDA, 1 Yr. Growth %	17.21	-42.4	-22.48	26.87	-5.67
EBITA, 1 Yr. Growth %	17.22	-42.42	-28.55	26.87	-5.68
EBIT, 1 Yr. Growth %	17.22	-43.9	-36.56	28.1	-6.7
Earnings From Cont. Operations, 1 Yr. Growth %	25.53	-40.28	-18.41	-86.98	1.06K
Net Income, 1 Yr. Growth %	18.47	-19.53	-15.99	-86.98	1.06K
Normalized Net Income, 1 Yr. Growth %	-0.94	-1.77	-33.42	31.55	-2.58
Diluted EPS Before Extra, 1 Yr. Growth %	42.2	-17.46	-7.02	-83.56	811.83
Accounts Receivable, 1 Yr. Growth %	17.86	-42.13	31.22	2.72	8.05
Inventory, 1 Yr. Growth %	-	-	-27.12	-17.21	16.15
Net Property, Plant and Equip., 1 Yr. Growth %	-57.14	3.05K	-12.11	-1.72	320.76
Total Assets, 1 Yr. Growth %	-7.32	32.93	0.98	4.63	25.68
Tangible Book Value, 1 Yr. Growth %	-23.18	-31	49.12	8.93	109.28
Common Equity, 1 Yr. Growth %	-23.18	36.42	19.29	2.4	69.69
Cash From Operations, 1 Yr. Growth %	16.19	-44.55	-30.07	33.76	4.37
Capital Expenditures, 1 Yr. Growth %	-	-	513.43	-34.31	318.89
Levered Free Cash Flow, 1 Yr. Growth %	16.41	-39.6	-16.01	22.63	-19.23
Unlevered Free Cash Flow, 1 Yr. Growth %	16.03	-37	-13.84	22.34	-19.82
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	22.53	-0.81	-10.99	4.05	15.1
Gross Profit, 2 Yr. CAGR %	22.44	-9.21	-18.32	6.13	8.15
EBITDA, 2 Yr. CAGR %	23.92	-17.83	-31.36	-3.66	9.4
EBITA, 2 Yr. CAGR %	23.93	-17.85	-34.11	-3.66	9.39
EBIT, 2 Yr. CAGR %	23.93	-18.91	-38.68	-8.75	9.33
Earnings From Cont. Operations, 2 Yr. CAGR %	38.97	-13.42	-30.2	-67.41	22.83
Net Income, 2 Yr. CAGR %	30.01	-2.36	-17.78	-66.93	22.83
Normalized Net Income, 2 Yr. CAGR %	3.79	-1.36	-16.3	-5.15	13.2
Diluted EPS Before Extra, 2 Yr. CAGR %	41.75	8.34	-12.39	-60.9	22.44
Accounts Receivable, 2 Yr. CAGR %	18.06	-17.41	-12.86	16.1	5.35
Inventory, 2 Yr. CAGR %	-	-	-	-22.32	-1.94
Net Property, Plant and Equip., 2 Yr. CAGR %	-39.7	1.01K	426.28	-7.06	103.35
Total Assets, 2 Yr. CAGR %	13.05	11	15.86	2.79	14.67
Tangible Book Value, 2 Yr. CAGR %	15.02	-27.2	1.43	27.45	50.99
Common Equity, 2 Yr. CAGR %	15.02	2.37	27.57	10.53	31.82
Cash From Operations, 2 Yr. CAGR %	18.87	-19.73	-37.73	-3.29	18.15
Capital Expenditures, 2 Yr. CAGR %	-	127.02	-	100.74	65.89
Levered Free Cash Flow, 2 Yr. CAGR %	17.16	-16.15	-26.88	2.65	-0.48
Unlevered Free Cash Flow, 2 Yr. CAGR %	16.53	-14.5	-24.45	3.79	-0.95
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	14.51	8.28	-2.68	-2.9	7.47
Gross Profit, 3 Yr. CAGR %	14.45	1.89	-7.98	-6.26	2.51
EBITDA, 3 Yr. CAGR %	16.02	-4	-18.19	-18.01	-4.33
EBITA, 3 Yr. CAGR %	16.03	-4.01	-20.4	-18.03	-4.34
EBIT, 3 Yr. CAGR %	16.03	-4.84	-24.12	-21.61	-8.07
Earnings From Cont. Operations, 3 Yr. CAGR %	-3.18	4.87	-15.11	-60.12	7.18
Net Income, 3 Yr. CAGR %	-12.37	10.79	-7.13	-55.52	8.22
Normalized Net Income, 3 Yr. CAGR %	-1.54	1.9	-11.97	-2.68	-4.3
Diluted EPS Before Extra, 3 Yr. CAGR %	-6.71	18.37	2.96	-49.84	11.71
Accounts Receivable, 3 Yr. CAGR %	9.95	-6.91	-3.63	-7.94	13.35
Inventory, 3 Yr. CAGR %	-	-	-	-	-11.18
Net Property, Plant and Equip., 3 Yr. CAGR %	-57.83	370.4	375.96	200.81	53.75
Total Assets, 3 Yr. CAGR %	19.11	19.33	7.55	11.99	9.91
Tangible Book Value, 3 Yr. CAGR %	39.26	-3	-7.54	3.87	50.36
Common Equity, 3 Yr. CAGR %	39.26	21.75	7.73	18.56	27.51
Cash From Operations, 3 Yr. CAGR %	17.63	-7.81	-23.34	-19.66	-0.8
Capital Expenditures, 3 Yr. CAGR %	-	77.4	216.2	-	156.52
Levered Free Cash Flow, 3 Yr. CAGR %	17.22	-6.06	-14.87	-13.13	-5.23
Unlevered Free Cash Flow, 3 Yr. CAGR %	15.78	-5.07	-13.09	-11.28	-4.77
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	24.02	8.81	3.53	6.57	4.08
Gross Profit, 5 Yr. CAGR %	24.24	5.05	0	4.31	-1.65
EBITDA, 5 Yr. CAGR %	28.24	3.47	-6.11	-3.45	-9.59
EBITA, 5 Yr. CAGR %	28.27	3.48	-7.64	-3.46	-9.6
EBIT, 5 Yr. CAGR %	28.27	2.95	-10.25	-6.01	-12.18
Earnings From Cont. Operations, 5 Yr. CAGR %	44.02	10.41	-15.05	-34.29	-1.59
Net Income, 5 Yr. CAGR %	34.89	9.78	-14.57	-31.69	3.86
Normalized Net Income, 5 Yr. CAGR %	27.47	6.03	-8.05	-0.49	-2.66
Diluted EPS Before Extra, 5 Yr. CAGR %	40.18	15.22	-9.02	-24	10.35
Accounts Receivable, 5 Yr. CAGR %	18.77	-1.9	0.19	1.69	-0.13
Net Property, Plant and Equip., 5 Yr. CAGR %	-49.57	75.05	79.95	145.9	238.72
Total Assets, 5 Yr. CAGR %	19.57	27.37	17.8	12.41	10.34
Tangible Book Value, 5 Yr. CAGR %	3.28	3.34	22.68	8.2	12.5
Common Equity, 5 Yr. CAGR %	3.28	18.43	34.46	17.13	16.78
Cash From Operations, 5 Yr. CAGR %	42.93	7.31	-8.8	-6.03	-8.86
Capital Expenditures, 5 Yr. CAGR %	-	-	-	86.4	144.29
Levered Free Cash Flow, 5 Yr. CAGR %	43.36	9.26	-3.12	-2.26	-9.38
Unlevered Free Cash Flow, 5 Yr. CAGR %	28.07	5.71	-2.57	-1.23	-8.43